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Dietary silicon is essential in the maintenance of bone and cartilage. However, the mechanism by which
silicon, in the form of silicates, triggers a biological response has never been uncovered. Here we de-
monstrate the incorporation of orthosilicic acid (Si(OH)4), the form of silicon in the body, within collagen
scaffolds for use as an in vitro platform to identify key genes affected by silicates. Ice-templated collagen–
silicate scaffolds, containing 0.21 wt% silicon, were validated by examining the mRNA levels for an array
of genes in human osteoblasts and mesenchymal stromal cells (MSC) after 48 h in culture. Several novel
genes, such as tumor necrosis factor alpha (TNF), were identiﬁed as having potential links to orthosilicic
acid, verifying that collagen–silicate scaffolds are a versatile platform for identifying novel mechanisms
in which silicates regulate musculoskeletal tissue.
& 2015 Published by Elsevier B.V.1. Introduction
Since work began on dietary silicates in the 1970s, there has
been no deﬁnitive explanation for the biological effects of silicates
either in vivo or in vitro [1,2]. The necessity of silicates has been
widely acknowledged, especially in bone, where dietary silicates
have been linked to increased bone mineral density [1,3]. How-
ever, the early studies have never been replicated, possibly due to
a lack in vital co-factors, or differences in experimental study de-
sign [2].
Even in vitro, results are often contradictory and, depending on
the study, silicates are reported to either increase or decrease the
expression of bone markers and collagen synthesis [4,5]. In Bio-
glasses, release of silicate and calcium ions drives osteoblastic
differentiation, but the effects of individual components remain
unclear [4,6–8]. Many factors contribute to this variability in-
cluding cell passage number and the silicate source [9–11].
The subtle effects of silicates have spurred efforts to use in vitro
models to understand the mechanism of action. Due to the inter-
actions of silicates with collagen ﬁbrillogenesis, the creation of
stable tissue engineering constructs is difﬁcult to achieve [12]. Itawelec),was hypothesized that soluble silicates could be introduced into a
scaffold composed of mature collagen which had already under-
gone ﬁbrillogenesis to create a stable platform. To validate the
model, the change in mRNA levels of human osteoblasts and
mesenchymal stromal cells (MSCs) in response to collagen–silicate
scaffolds was tested. The results veriﬁed that the scaffolds were a
viable tool for studying silicates and allowed for the identiﬁcation
of novel genes for further investigation.2. Materials and methods
2.1. Scaffold production
Unless noted, all reagents are from Sigma Aldrich (UK). Scaf-
folds were prepared by hydrating 1 wt% insoluble, bovine Achilles
collagen in 0.05 M acetic acid, at pH 2, and homogenizing. Slurry
was frozen in stainless steel molds at 30 °C for 90 min, then
lyophilized using a Virtis freeze drier (SP Industries, USA) at 0 °C
for 20 h under a vacuum of less than 100 mTorr. Cross-linking was
done using carbodiimides: a 5:2:1 ratio of N-(3-Dimethylamino
propyl)-N′-ethylcarbodiimide hydrochloride (EDC): N-Hydro-
xysuccinimide (NHS): collagen COOH groups in 70% ethanol [13].
Within the current study, “silicate” will be used to refer to a
silicon-containing molecule, such as orthosilicic acid, while “sili-
con” will be reserved for compositional analysis. Orthosilicic acid,
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Fig. 1. Silicates were introduced into collagen scaffolds at different phases of
production.
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lution and introduced to scaffolds at various stages, Fig. 1. During
collagen hydration, orthosilic acid was added to solutions of
0.05 M acetic acid at 10, 20, 30, and 100 vol%. To introduce silicates
after freeze drying, scaffolds were soaked for 1 h in orthosilicic
acid (pH 7), before or after cross-linking, with an additional con-
trol without cross-linking.
Scaffold structure was characterized using scanning electron
microscopy (JEOL 820), and micro-computed tomography (mCT,
Skyskan 1172). Chemical composition was investigated using en-
ergy dispersive x-ray spectroscopy (EDX) on a JEOL-5800LV under
low vacuum (25–30 Pa) without platinum coating, and using in-
ductively coupled plasma optical emission spectroscopy (ICP-OES)
on acid digested samples.
2.2. Scaffold characterization
2.2.1. Cell culture
Two types of scaffolds were tested: 1 wt% collagen scaffold and
1 wt% collagen–silicate scaffold (orthosilicic acid introduced after
cross-linking). Human osteoblasts and MSCs were isolated from
tissue removed during joint replacement following informed
consent. Ethical approval was obtained from Cambridgeshire Local
Research Ethics Committee (LREC no. 06/Q0108/213). Both cell
types were obtained from the same patient and used before pas-
sage 5. Osteoblasts were isolated by a method described by Meyer
et al. and cultured in osteoblast medium (10% fetal bovine serum
(FBS, Invitrogen), 30 μg/ml ascorbic acid, 1% penicillin/strepto-
mycin in McCoys 5 A (Invitrogen)) [14].
Early MSCs were isolated from trabecular bone and en-
zymatically digested in the same way as osteoblasts. MSCs were
sorted from the cell population using magnetic beads (Miltenyi
Biotech) conjugated to an antibody against CD271, using the same
principle developed by Jones et al. [15]. Cells were cultured in MSCmedium (10% FBS, 30 ug/ml ascorbic acid, 1% penicillin/strepto-
mycin in Minimal Essential Medium (Invitrogen)) and analyzed by
ﬂow cytometry (Beckman Coulter) prior to use.
Scaffolds (552 mm3) were sterilized in 70% ethanol and
seeded with 1.5105 cells in 10 μl medium, and incubated 2 h
(37 °C) before ﬂooding with complete medium.
2.3. Quantitative polymerase chain reaction (qPCR)
RNA was harvested after 48 h with Qiazol (Qiagen) and puriﬁed
with RNeasys Mini Kit columns (Qiagen) and on-column DNase
digestion. RNA from three replicates was pooled to make cDNA
with RT2 First Strand Kit (Qiagen). PCR arrays were used for MSCs
(RT2 Proﬁler PCR array, #330231 PAHS-082ZA, Qiagen) and os-
teoblasts (RT2 Proﬁler PCR Array, #330231 PAHS-026ZA, Qiagen).
Any dissociation curves which were not single peaks were ex-
cluded from the ﬁnal analysis. Results are presented as fold reg-
ulations. Fold regulation is equal to the fold change for values
greater than 1.0; otherwise fold regulation is the negative inverse
of the fold change.3. Results and discussion
3.1. Collagen–silicate Scaffolds
The amount of silicon present within the scaffolds was de-
pendent on when silicates were introduced into the scaffold, Fig. 2.
Incorporation of silicates during initial hydration was successful
only with 100% orthosilicic acid. The key features of the scaffolds
were not signiﬁcantly altered by incorporation of silicates; the
percentage porosity remained at 86%, with a mean pore diameter
of 38 mm in the dry state. All scaffolds were interconnected, porous
structures, suitable for tissue engineering, Fig. 2.
Incorporation of the silicate after freeze drying was only suc-
cessful after cross-linking or when the cross-linking step was
omitted. While the precise interactions between orthosilicic acid
and collagen ﬁbrils is undetermined, silicates can bind collagen
ﬁbrils, and, in hydrogels, they can affect mechanical stability
[10,12]. As it is unlikely that all of the silicate could diffuse from
the scaffold after 5 hours, the disappearance of silicon after cross-
linking might be due to competition with the cross-linking agent
for the same binding site along the collagen chain. When the
scaffold was hydrated in 100% orthosilicic acid, the silicates may
have saturated the collagen chains so that it could not be com-
pletely removed by the carbodiimide reaction. While some inter-
action with the carbodiimide cross-linking agent is suggested,
with no statistical change in the percentage porosity, or the scaf-
fold wall thickness (7.5–8 mm), it is not believed that large differ-
ences in the mechanical properties would be observed in this
system. However, further studies on the cross-linking mechanism
will require an in-depth study of the mechanical properties.
Using ICP, it was found that scaffolds soaked in silicates after
cross-linking contained 0.21 wt% silicon, compared with untreated
scaffolds (less than 0.004 wt%). Low levels of silicon in the control
was expected due to the prevalence of silicates in the environment
(e.g. glassware and water) [2]. In addition to silicon, several trace
elements were present including sulfur, in the di-sulﬁde bonds, and
chlorine, from the hydrochloric acid used to adjust the pH of collagen
suspensions, Fig. 2. Due to the constrained ﬂuid ﬂow in the scaffold,
the micro-environment around the cell would be difﬁcult to predict.
It is likely that the local silicate concentration is higher than if the
same amount of silicate were added to cell culture medium. Further,
it is not known if the form of silicate is altered during scaffold pro-
duction, or in what form the silicate interacts with cells, making
comparison to systems based on soluble silicates difﬁcult [11].
Fig. 2. The chemical composition of collagen–silicate scaffolds was dependent on when silicates were introduced. (a) Composition from EDX; all measurements are an
average of three repeats, standard deviations were o20% of the mean in every case. All scaffolds had interconnected porosity: (b) without silicates, (c) hydrated in 100%
ortho-silicic acid, and (d) soaked in silicates after cross-linking. Scale bar 200 mm. (xlink¼cross-linking).
Fig. 3. Fold regulation of mRNA levels in (a) osteoblasts and (b) MSCs after cul-
turing on collagen–silicate scaffolds (relative to untreated collagen scaffolds) after
48 hours.
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within scaffolds was sufﬁcient to inﬂuence mRNA levels, without
affecting the scaffold stability.
3.2. Biological activity of collagen–silicate scaffolds
The collagen–silicate scaffold chosen for cell testing was a
scaffold made with orthosilicic acid introduced after cross-linking.
The composition varied from the control scaffold only by the
presence of silicon, Fig. 2. Given the link between silicon and
calciﬁcation, osteoblasts are often used to study silicates, but
connective tissues also contain high amounts of silicates [1]. Thus
MSCs, which have the potential to differentiate into both bone and
connective tissue lineages, were also tested. Both cell types came
from the same individual, ensuring that differences in cell sensi-
tivity were due to cell phenotype and not individual donor
variation.
The biological activity of both cell types was altered by the
incorporation of silicates into the collagen scaffold, although os-
teoblasts showed greater sensitivity to silicates than MSCs, Fig. 3.
The largest down-regulation in gene expression in osteoblasts was
observed for tumor necrosis factor alpha (TNF, 5.23 fold) and
bone morphogenetic protein 4 (BMP4, 3.41 fold). In contrast, the
greatest up-regulation was in expression of CD36 (4.06 fold) and
matrix metallopeptidase 10 (MMP10, 2.24 fold). Interestingly,
none of the genes strongly up-regulated are currently linked to
mineralization or calciﬁcation, the major research area of interest
for silicates [16]. Also, surprisingly, collagen genes were un-
affected. However, like the current study, there are reports in lit-
erature that the presence of silicates and calcium ions can greatly
affect the cell cycle and proliferation of osteoblast progenitors [6].
The MSCs were not greatly affected by incorporation of silicate
into collagen scaffolds, which hasbeen previously noted in another
study [8]. In the presence of silicates, integrin-beta 1 (ITGB1, 1.91)
and bone morphogenetic protein 6 (BMP6, 1.71) showed the
greatest up-regulation in mRNA levels, while the largest down-
regulation was observed in the expression of TNF (2.24) and
platelet-derived growth factor receptor beta (PDGFRB, 1.58).
Interestingly, despite differences in sensitivity, the mRNA level of
TNF was down-regulated by both osteoblasts and MSCs. This
veriﬁed that the constructs were able to inﬂuence biological ac-
tivity, possibly due to silicates modifying cell adhesion to thescaffold through integrin binding, or interacting with cells in
bound form (or following release) from the scaffold. Both of these
effects could alter intracellular signaling, resulting in changes in
mRNA levels, either through transcriptional or post-transcriptional
mechanisms.
Cellular phenotype is a result of an interconnected network of
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a complex chain of events. Many of the genes with the greatest
change in mRNA levels are genes which can drive multiple cellular
events, like growth factors. The most consistent down-regulation
was TNF, a cytokine associated with osteoporosis and inﬂamma-
tion [17]. In vitro, TNF inhibits differentiation of osteoblasts from
precursors and reduces matrix production while stimulating os-
teoclast resorption [18]. In vivo, TNF can delay early proliferation of
osteoblasts and matrix formation, by interacting with other
growth factors in the bone metabolic pathway [19]. As TNF has not
been previously associated with the biological activity of silicates,
it may offer a new gene of interest for further study.
One of the advantages of the collagen–silicate scaffolds was the
absence of other ions, which might inﬂuence gene expression or
modulate the behavior of the silicate. In materials, such as silicate
substituted-hydroxyapatite (SiHA) or Bioglass, their dissolution
releases, not only silicates, but calcium and phosphate ions as well.
From such studies, it has been noted that signiﬁcant biological
effects are triggered by the presence of silicon, at levels around
12 μM, even when calcium and phosphate levels do not vary [20].
However, these results were dependent on co-culture systems and
there is evidence that important interactions occur between MSCs
and osteoblasts with endothelial cells, which promote the forma-
tion of vascular structures and the osteogenic activity of the MSCs
[20–22]. Cell–cell interactions may thus provide a link between
the effects of silicates on cells and increased bone formation
in vivo. In summary, the study we have carried out is a step to-
wards unifying the silicate literature by providing a platform for
examining the inﬂuence of silicates on gene expression. The cul-
ture model we have developed would be an ideal system on which
to further investigate endothelial–mesenchymal interactions with
silicon.4. Conclusion
Current in vitro models for studying the biological effects of
dietary silicates on connective tissue cells are hampered by silicate
interactions with processes such as collagen ﬁbrillogenesis. Using
orthosilicic acid and insoluble collagen, a method for producing
stable collagen–silicate scaffolds, incorporating 0.21 wt% silicon,
was presented. The collagen–silicate scaffold was validated as a
model system for studying silicates by examining changes in
mRNA levels of human osteoblasts and MSCs. In both cell types,
the expression of powerful growth factors was affected, suggesting
potential targets for the mechanism of action of silicates and of-
fering researchers a new method to gain insight into the biological
effects of silicates.Acknowledgments
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